238 filings
DEF 14A
REVB
Revelation Biosciences Inc
Definitive proxy
15 Apr 24
5:33pm
PRE 14A
REVB
Revelation Biosciences Inc
Preliminary proxy
5 Apr 24
4:02pm
8-K
REVB
Revelation Biosciences Inc
22 Mar 24
Results of Operations and Financial Condition
4:22pm
10-K
2023 FY
REVB
Revelation Biosciences Inc
Annual report
22 Mar 24
4:01pm
8-K
REVB
Revelation Biosciences Inc
11 Mar 24
Regulation FD Disclosure
9:53pm
SC 13G/A
hfa11c9
13 Feb 24
REVELATION BIOSCIENCES / Lind Global Fund II ownership change
8:12pm
8-K
ibj5bvn5110qykf
8 Feb 24
Revelation Biosciences Inc. Announces Pricing of $6.2 Million Public Offering
4:01pm
424B3
n8jq0180en6pv
2 Feb 24
Prospectus supplement
4:06pm
EFFECT
cujfro
1 Feb 24
Notice of effectiveness
12:15am
8-K
wbhxg 8uz9l
30 Jan 24
Developing innovative therapeutics to address unmet needs Corporate Presentation / January 2024 www.revbiosciences.com
5:21pm
CORRESP
fz95 mar5ce
30 Jan 24
Correspondence with SEC
12:00am
CORRESP
y6q2ri9
29 Jan 24
Correspondence with SEC
12:00am
8-K
0us3 i7pyt38qj7f
23 Jan 24
Material Modifications to Rights of Security Holders
4:18pm
8-K
2j3xbuth
22 Jan 24
Submission of Matters to a Vote of Security Holders
4:01pm
SC 13G
fvw748qummhn23nagy
3 Jan 24
REVELATION BIOSCIENCES / SABBY MANAGEMENT ownership change
8:36am
UPLOAD
adfg dbnatrf
2 Jan 24
Letter from SEC
12:00am